Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer

Ítems similars

• Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer: A Systematic Review and Meta-analysis
  per: Simons, Janine M., et al.
  Publicat: (2019)
• Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases
  per: van Nijnatten, T. J. A., et al.
  Publicat: (2017)
• Critical dialogue: recent advancements toward omission of axillary lymph node dissection in clinically node positive breast cancer patients treated with neoadjuvant chemo-immuno therapy: impact on radiology practice
  per: Florien J. G. van Amstel, et al.
  Publicat: (2025-03-01)
• De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study
  per: Simons, J. M., et al.
  Publicat: (2020)
• Role of Combined Sentinel Lymph Node Biopsy and Axillary Node Sampling in Clinically Node-Negative Breast Cancer
  per: Edwards, K. J., et al.
  Publicat: (2015)